Asunto(s)
Ácido Pantoténico/análogos & derivados , Trasplante de Piel/métodos , Infecciones de los Tejidos Blandos/cirugía , Colgajos Quirúrgicos , Antiinfecciosos/uso terapéutico , Terapia Combinada , Geles , Humanos , Ácido Pantoténico/uso terapéutico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Trasplante AutólogoRESUMEN
Results of treatment of 207 patients with purulent-necrotic complications of the diabetic foot syndrome (DFS) were analyzed. Tactics of treatment was determined considering the DFS form presented, stage of the extremity ischemia, character and severity of purulent-inflammatory affection and the patient's homeostasis state. Urgent operation was performed in 79 (38.1%) patients, in 38 (48.1%) of them--amputation of extremity. In late follow-up period 98 (47.3%) patients were operated on, in 76 (75.5%) of them necrectomy or small amputation was performed, allowing to preserve the extremity. Conservative treatment was conducted in 30 (14.5%) patients with trophic ulcers. Application of elaborated program of treatment had permitted to increase the preservation frequency of supporting function of foot from 28.9 to 56.3% and to reduce general lethality from 18.3 to 13.5%.